Edwards Lifesciences Unveils Minimally Invasive Hemodynamic Monitoring Device

Strategic Insights -

Edwards Lifesciences Corporation, a leading manufacturer of hemodynamic-monitoring technologies, has previewed its new minimally invasive hemodynamic monitoring device, the Edwards FloTrac sensor, at the Society of Critical Care Medicine's (SCCM) 34th Critical Care Congress. The device is designed to provide clinicians with a less invasive alternative to traditional pulmonary artery catheters for monitoring cardiac output and other vital signs in critically ill patients.

Key Takeaways:

  • The Edwards FloTrac sensor is a minimally invasive hemodynamic monitoring device that provides continuous cardiac measurements by accessing data directly from an arterial line.
  • The device is designed for patients who require hemodynamic monitoring but do not need the full range of parameters offered by Edwards' line of Swan-Ganz catheters.
  • Initial clinician feedback from FloTrac sensor pilot studies has been very positive, with a preliminary study of 11 heart surgery patients demonstrating reliable and accurate cardiac output measurements.
  • The device is expected to be widely available in the U.S. and Europe later this year, pending regulatory approvals.
  • The FloTrac sensor is an alternative to traditional pulmonary artery catheters, which are threaded into a patient's heart to collect vital sign data.
  • The device uses data from an arterial line, a small catheter inserted into the patient's radial artery, to provide key continuous cardiac measurements.

Statistics:

  • The FloTrac sensor provides cardiac output measurements, oxygen saturation levels, blood pressure, and blood volume data.
  • The device is designed for use in critical care and intensive care settings.
  • 11 patients participated in a preliminary study of the FloTrac sensor, which demonstrated reliable and accurate cardiac output measurements.
  • The device is expected to be widely available in the U.S. and Europe later this year.

Sources:

  • Health & Medicine Week
  • Caption: Society of Critical Care Medicine (SCCM)
  • Edwards Lifesciences Corporation
  • University of California San Diego School of Medicine
  • Health & Medicine Week via NewsRx.com & NewsRx.net